Precise Biometrics AB (publ) (PREC.ST)
SEK 5.1
(1.19%)
SEK 5.1
(1.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.76 Million | 3.93 Million | -1.49 Million | 21.79 Million | -477 Thousand | -26.05 Million |
| Net Income | -26.4 Million | -20.01 Million | -14.07 Million | -5.86 Million | 224 Thousand | -18.22 Million |
| Depreciation & Amortization | 24.76 Million | 21.15 Million | 3.82 Million | 2.99 Million | 2.95 Million | 10.22 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -9.52 Million | 3.07 Million | -2.58 Million | 15.81 Million | -11.96 Million | -16.71 Million |
| Other non-cash items | 401 Thousand | -284 Thousand | 11.33 Million | 8.85 Million | 8.3 Million | -1.33 Million |
| Investing Cash Flow | -25.31 Million | -60 Million | -30.25 Million | -17.79 Million | -5.84 Million | -11.38 Million |
| Investments in PPE | -15.31 Million | -21.74 Million | -19.58 Million | -17.79 Million | -5.84 Million | -11.38 Million |
| Acquisitions | -10 Million | -38.26 Million | -10.67 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -14.1 Million | -21.45 Million | -16.75 Million | -15.73 Million | -5.53 Million | -10.97 Million |
| Financing Cash Flow | 37.28 Million | 38.31 Million | 19.54 Million | -1.37 Million | 396 Thousand | -96 Thousand |
| Debt repayment | -2.25 Million | -1.9 Million | -1.27 Million | -1.37 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -326 Thousand | - | - | - | -96 Thousand |
| Common Stock Issuance | 39.54 Million | 44.47 Million | 22.9 Million | - | 396 Thousand | - |
| Other Financing Activities | 1000.00 | -2.03 Million | -2.08 Million | -1.37 Million | 396 Thousand | -96 Thousand |
| Accounts receivables | -7.08 Million | 11.07 Million | -6.28 Million | 15.69 Million | -9.59 Million | -6.42 Million |
| Accounts payables | -2.39 Million | -8.23 Million | 3.19 Million | 1.22 Million | -2.42 Million | -10.08 Million |
| Inventory | -48 Thousand | 237 Thousand | 504 Thousand | -1.05 Million | - | - |
| Other working capital | -2.39 Million | -8.23 Million | 3.19 Million | -52 Thousand | 52 Thousand | -207 Thousand |
| Cash at beginning of period | 46.4 Million | 64.1 Million | 76.25 Million | 73.67 Million | 79.54 Million | 116.95 Million |
| Cash at end of period | 47.53 Million | 46.4 Million | 64.1 Million | 76.25 Million | 73.67 Million | 79.54 Million |
| Capital Expenditure | -15.31 Million | -21.74 Million | -19.58 Million | -17.79 Million | -5.84 Million | -11.38 Million |
| Effect of forex changes on cash | -83 Thousand | 67 Thousand | 52 Thousand | -39 Thousand | 57 Thousand | 125 Thousand |
| Net cash flow / Change in cash | 1.12 Million | -17.69 Million | -12.15 Million | 2.58 Million | -5.86 Million | -37.41 Million |
| Free Cash Flow | -26.07 Million | -17.8 Million | -21.07 Million | 3.99 Million | -6.32 Million | -37.44 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.56 Million | -2.96 Million | -26.4 Million | -4.96 Million | -7.28 Million | -6.89 Million |
| Depreciation & Amortization | 5.75 Million | 5.89 Million | 24.76 Million | 6.01 Million | 6.19 Million | 6.32 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.77 Million | -5.78 Million | -9.52 Million | -3.75 Million | -6.48 Million | 5.86 Million |
| Other non-cash items | 7.62 Million | 17.59 Million | 401 Thousand | -120 Thousand | 30 Thousand | 126 Thousand |
| Investing Cash Flow | -2.59 Million | -3.02 Million | -25.31 Million | -13.28 Million | -2.97 Million | -3.85 Million |
| Investments in PPE | -2.67 Million | -3.05 Million | -15.31 Million | -3.28 Million | -2.97 Million | -3.85 Million |
| Acquisitions | 76 Thousand | 31 Thousand | -10 Million | -10 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.59 Million | -3.02 Million | -14.1 Million | -2.92 Million | -2.16 Million | -3.82 Million |
| Financing Cash Flow | -640 Thousand | -623 Thousand | 37.28 Million | -630 Thousand | -690 Thousand | 39.55 Million |
| Debt repayment | -639 Thousand | -622 Thousand | -2.25 Million | -630 Thousand | -567 Thousand | -532 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1000.00 | -1000.00 | - | - | - | - |
| Common Stock Issuance | - | - | 39.54 Million | -9.97 Million | - | 49.52 Million |
| Other Financing Activities | -639 Thousand | - | 1000.00 | 9.97 Million | -123 Thousand | -9.43 Million |
| Accounts receivables | 6.36 Million | -7.3 Million | -7.08 Million | -9.07 Million | 35 Thousand | 5.82 Million |
| Accounts payables | -2.59 Million | 1.45 Million | -2.39 Million | 5.2 Million | -6.52 Million | 195 Thousand |
| Inventory | 2000.00 | 66 Thousand | -48 Thousand | 108 Thousand | 1000.00 | -157 Thousand |
| Other working capital | -2.59 Million | 1.45 Million | -2.39 Million | 5.2 Million | -6.52 Million | 195 Thousand |
| Cash at beginning of period | 41.14 Million | 47.53 Million | 46.4 Million | 64.38 Million | 75.58 Million | 34.43 Million |
| Cash at end of period | 41.74 Million | 41.14 Million | 47.53 Million | 47.53 Million | 64.38 Million | 75.58 Million |
| Capital Expenditure | -2.67 Million | -3.05 Million | -15.31 Million | -3.28 Million | -2.97 Million | -3.85 Million |
| Effect of forex changes on cash | -18 Thousand | 91 Thousand | -83 Thousand | -106 Thousand | 1000.00 | 24 Thousand |
| Net cash flow / Change in cash | 598 Thousand | -6.38 Million | 1.12 Million | -16.84 Million | -11.2 Million | 41.15 Million |
| Free Cash Flow | 1.18 Million | -5.88 Million | -26.07 Million | -6.11 Million | -10.51 Million | 1.57 Million |
BASFY
8025
SDA
000159
ALIV-SDB
COFB